Global Cardiac Point-of-Care (POC) Market: Overview
Cardiac POC is a type of blood test which also includes testing of the cholesterol and coagulation. Cardiac POC helps in the detection of the enzyme that is released if a person is suffering from critical cardiac illness. Enzymes can be lactate, brain natriuretic peptides, troponin, and dehydrogenase isoenzymes. Cardiac POCs are also helpful in detecting other conditions such as angina and myocardial infarction. The cardiac POC provides precise information about the markers that are released when the heart fails. Owing to the test the turnaround time minimizes thus helping in early diagnosis.
Global Cardiac Point-of-Care (POC) Market: Growth Factors
Some of the factors that are driving the growth of the cardiac point-of-care (POC) market are the growing numbers of the cardiac patients and the increasing requirement to diagnose these diseases. Moreover, the decrease in the turnaround time and availability of the technically advanced products having enhanced characteristics such as automation and miniaturization is also propelling the growth of the market.
Factors that are limiting the growth of the cardiac point-of-care (POC) market are a financial downturn and the concerns regarding reimbursement. One of the challenges faced by the market is the lack of precise actions in detecting the existence of the cardiovascular diseases.
The introduction of the novel products, mergers and acquisitions by the market players, and the increasing diagnostic facilities are some of the trends that are positively affecting the growth of the market.
Global Cardiac Point-of-Care (POC) Market: Segmentation
The cardiac point-of-care (POC) market is segmented based on the device type. On the basis of the device type, the market is segregated into cardiac POC testing analyzer and cardiac POC test kits. The cardiac POC test kits are further sub-divided into biomarker test, myoglobin biomarker test, myoglobin biomarker test, cardiac troponin biomarker test, hybrid test, creatine kinase-myoglobin (CK-MB), and brain natriuretic peptide (BNP) test.
Global Cardiac Point-of-Care (POC) Market: Regional Analysis
North America is dominating the cardiac point-of-care (POC) market which is followed by Europe. The major factors that are driving the market are the growing demand for the home healthcare, increased number of cardiac patients, and the favorable government policies. Other factors that are positively influencing the market growth are favorable healthcare reforms, early adoption of the advanced technologies, advanced healthcare infrastructure, a wide range of upgradation in the Clinical Laboratory Improvement Amendments (CLIA) waved measures and the increased health awareness among the patients. The cardiac point-of-care (POC) market in Europe is positively affected due to the increased occurrences of chronic ailments, improved focus in the advancement of the connected healthcare, and the growing demand for the POC testing devices.
The cardiac point-of-care (POC) market in the Asia Pacific is expected to develop at a rapid rate in the coming years owing to the increasing healthcare spending and the growing awareness about the diagnostic treatments.
Global Cardiac Point-of-Care (POC) Market: Competitive Players
Some of the most important market players in the cardiac point-of-care (POC) market include Alere Inc., Boston Scientific Corp., Abbott Laboratories, Roche Diagnostics, and Medtronic Inc., among others.
Global Cardiac Point-of-Care (POC) Market: Regional Segment Analysis
What Reports Provides